Inhibikase™ Novel Therapies for Patients with Pulmonary Arterial Hypertension
| Drug Target | Drug Candidate | Modality | Disease indication | Preclinical development | Phase 1/1b | Phase 2 | Phase 3 |
|---|---|---|---|---|---|---|---|
| Cardiopulmonary Disease | |||||||
| PDGFRα/PDGFRβ/c-KIT | IkT-001 | Small molecule | Pulmonary Arterial Hypertension (orphan indication) |
Preclinical development Phase complete
|
Phase 1/1b Phase complete
|
Phase 2 Phase in progress
|
Phase 3 Phase not started
|